Clinigen Group (CLIN)

 

Latest News

Clinigen achieves positive Cardioxane CHMP opinion

Clinigen's specialty pharma division has achieved a positive CHMP opinion in Europe to modify the current product infor...

Clinigen achieves positive Cardioxane CHMP opinion

RNS Number: 7353F Clinigen Group plc 22 May 2017 RNS Reach 22 May 2017 Clinigen achieves positive CHMP opinion concerning Cardioxane in Europe Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that its Specialty Pharma (SP) division has achieved a positive CHMP opinion in Europe to mo...

Fund manager's favourite small-cap pharma shares

If you're looking for capital growth, don't bother with big pharma, argues fund manager Paul Mumford. He tells Lee Wild...

Clinigen and TESARO launch European MA programme

Clinigen Group's Idis managed access division and TESARO Inc have partnered to launch a managed access programme in...

All News

DateHeadlineSource
22-05-17Clinigen achieves positive Cardioxane CHMP opinionStockMarketWire
22-05-17Clinigen achieves positive Cardioxane CHMP opinionRNS
18-05-17Fund manager's favourite small-cap pharma shares Interactive Investor
11-05-17Clinigen and TESARO launch European MA programmeStockMarketWire
11-05-17Clinigen and TESARO launch European MA ProgramRNS
09-05-17Director Deals - Clinigen Group (CLIN)StockMarketWire
03-05-17Holding(s) in CompanyRNS
25-04-17Clinigen and Onxeo initiate MA programme in EuropeRNS
21-04-17Holding(s) in CompanyRNS
04-04-17Broker Forecast - Numis issues a broker note on Clinigen GroupStockMarketWire
16-03-17Clinigen and Diurnal partner for MA programmeStockMarketWire
16-03-17Clinigen and Diurnal partner for MA programmeRNS
16-03-17Launch of a European Patient Access programmeRNS
15-03-17Clinigen hikes divi as gross profits rise StockMarketWire
15-03-17Half-year ReportRNS
10-03-17First-in-class Fycompa? approved in South AfricaRNS
09-03-17Holding(s) in CompanyRNS
28-02-17Halaven? (eribulin) launches in South AfricaRNS
24-02-17Broker Forecast - Peel Hunt issues a broker note on Clinigen GroupStockMarketWire
22-02-17Notification of half year results dateRNS
25-01-17Broker Forecast - Stifel issues a broker note on Clinigen GroupStockMarketWire
25-01-17Broker Forecast - N+1 Singer issues a broker note on Clinigen GroupStockMarketWire
25-01-17Clinigen gross profit up 34%StockMarketWire
25-01-17HY trading updateRNS
17-01-17Clinigen initiates programme for TESARO inhibitorStockMarketWire
17-01-17Clinigen initiates program for TESARO's niraparibRNS
13-01-17Change of Joint BrokerRNS
09-01-17Clinigen and Cumberland enter agreement for TotectStockMarketWire
09-01-17Clinigen and Cumberland enter agreement for TotectRNS
15-12-16Clinigen signs agreement with BioQ PharmaRNS
01-12-16Clinigen collaborates with Eisai in South AfricaStockMarketWire
01-12-16Clinigen collaborates with Eisai in South AfricaRNS
14-11-16Director Deals - Clinigen Group (CLIN)StockMarketWire
14-11-16Director/PDMR ShareholdingRNS
11-11-16Clinigen resolutions passed at AGMStockMarketWire
11-11-16Result of AGMRNS
11-11-16Clinigen says FY trading in-lineStockMarketWire
11-11-16AGM StatementRNS
10-11-16Holding(s) in CompanyRNS
04-11-16Capital Markets DayRNS

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory